These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
779 related items for PubMed ID: 26725259
1. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry. Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H, J-RHYTHM Registry Investigators. J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259 [Abstract] [Full Text] [Related]
2. Use of warfarin in elderly patients with non-valvular atrial fibrillation -- subanalysis of the J-RHYTHM Registry. Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H, J-RHYTHM Registry Investigators. Circ J; 2015 Mar; 79(11):2345-52. PubMed ID: 26329097 [Abstract] [Full Text] [Related]
3. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study. Chan EW, Lau WC, Siu CW, Lip GY, Leung WK, Anand S, Man KK, Wong IC. Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342 [Abstract] [Full Text] [Related]
4. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry. Wang C, Yang Z, Wang C, Wang Y, Zhao X, Liu L, Wang DZ, Li H, Wang Y. J Stroke Cerebrovasc Dis; 2014 Aug; 23(5):1157-63. PubMed ID: 24291013 [Abstract] [Full Text] [Related]
5. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Rost NS, Giugliano RP, Ruff CT, Murphy SA, Crompton AE, Norden AD, Silverman S, Singhal AB, Nicolau JC, SomaRaju B, Mercuri MF, Antman EM, Braunwald E, ENGAGE AF-TIMI 48 Investigators. Stroke; 2016 Aug; 47(8):2075-82. PubMed ID: 27387994 [Abstract] [Full Text] [Related]
6. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Yasaka M, Minematsu K, Yamaguchi T. Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841 [Abstract] [Full Text] [Related]
7. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L. Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [Abstract] [Full Text] [Related]
8. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China. Yang X, Li Z, Zhao X, Wang C, Liu L, Wang C, Pan Y, Li H, Wang D, Hart RG, Wang Y, Wang Y, China National Stroke Registry II Investigators. Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643 [Abstract] [Full Text] [Related]
9. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE. JAMA; 2003 Nov 26; 290(20):2685-92. PubMed ID: 14645310 [Abstract] [Full Text] [Related]
10. Effect of Addition of a Statin to Warfarin on Thromboembolic Events in Japanese Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. Kumagai N, Nusser JA, Inoue H, Okumura K, Yamashita T, Kubo T, Kitaoka H, Origasa H, Atarashi H, J-RHYTHM Registry Investigators. Am J Cardiol; 2017 Jul 15; 120(2):230-235. PubMed ID: 28532776 [Abstract] [Full Text] [Related]
11. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC, Albers GW. Stroke; 2007 Mar 15; 38(3):874-80. PubMed ID: 17255547 [Abstract] [Full Text] [Related]
14. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE. N Engl J Med; 2003 Sep 11; 349(11):1019-26. PubMed ID: 12968085 [Abstract] [Full Text] [Related]
15. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Yamaguchi T. Stroke; 2000 Apr 11; 31(4):817-21. PubMed ID: 10753981 [Abstract] [Full Text] [Related]
16. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY. J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744 [Abstract] [Full Text] [Related]
17. Warfarin anticoagulation intensity in Japanese nonvalvular atrial fibrillation patients: a J-RHYTHM Registry analysis. Yamashita T, Inoue H, Okumura K, Atarashi H, Origasa H, J-RHYTHM Registry Investigators. J Cardiol; 2015 Mar 10; 65(3):175-7. PubMed ID: 25169015 [Abstract] [Full Text] [Related]
20. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation. Guo Y, Wang H, Tian Y, Wang Y, Lip GYH. Chest; 2015 Jul 10; 148(1):62-72. PubMed ID: 25501045 [Abstract] [Full Text] [Related] Page: [Next] [New Search]